Bavar­i­an Nordic's mon­key­pox vac­cine wins pos­i­tive opin­ion from EMA com­mit­tee

With de­mand ris­ing for Bavar­i­an Nordic’s small­pox vac­cine, Eu­ro­pean of­fi­cials have giv­en the thumbs up to ex­pand the la­bel to in­clude mon­key­pox.

Im­vanex, mar­ket­ed as Jyn­neos in the US, has been ap­proved in Eu­rope to treat small­pox since 2013. On Fri­day, the EMA’s Com­mit­tee for Med­i­c­i­nal Prod­ucts for Hu­man Use (CHMP) rec­om­mend­ed adding a mon­key­pox in­di­ca­tion to the la­bel, as glob­al cas­es surge past 15,000. The la­bel ex­pan­sion still needs to be ap­proved by the Eu­ro­pean Com­mis­sion be­fore it’s of­fi­cial.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER